about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Pfiz­er's for­mer top ex­ec­u­tives pitched changes to board as part of ac­tivist's plan

9 months ago
People
Pharma

BAR­DA doles out $72M to Sanofi, GSK and CSL for bird flu vac­cine sup­ply

9 months ago
Pharma
FDA+

J&J dis­con­tin­ues mid-stage dengue study, cit­ing de­pri­or­i­ti­za­tion of com­mu­ni­ca­ble dis­ease work

9 months ago
R&D
Pharma

Ex­clu­sive: Re­lay Ther­a­peu­tics cuts an­oth­er 10% of com­pa­ny, cit­ing con­tin­ued stream­lin­ing ef­forts

9 months ago
People
R&D

Wave’s new cap­i­tal ex­tends cash run­way in­to 2027, CEO says

9 months ago
R&D

J&J and Bay­er to lay off al­most 300 staffers in New Jer­sey

9 months ago
People
Pharma

Cal­i­for­ni­a's Gavin New­som ve­toes bi­par­ti­san PBM re­form bill

9 months ago
Pharma

Kezar halts mid-stage lu­pus study af­ter four deaths

9 months ago
R&D

Rivus de­tails weight loss da­ta in heart fail­ure pa­tients and preps for new fundraise

9 months ago
Startups
R&D

FDA lifts hold on Bio­mea’s di­a­betes tri­als

9 months ago
Pharma
FDA+

Ex­clu­sive: J&J folds car­dio­vas­cu­lar and meta­bol­ic drug unit

9 months ago
R&D

Bal­ti­more sues Bio­gen, say­ing the com­pa­ny col­lud­ed with PBMs to min­i­mize gener­ic com­pe­ti­tion

9 months ago
Pharma
Law

SIGA fires for­mer NYC Covid ad­vi­sor af­ter se­cret record­ings de­tail pan­dem­ic-era par­ties

9 months ago
People
Pharma

Wave rides new Phase 2 DMD da­ta as it sets sights on ac­cel­er­at­ed ap­proval

9 months ago
R&D

Sanofi's Sar­clisa gets ap­proved as a first-line op­tion for some pa­tients new­ly di­ag­nosed with mul­ti­ple myelo­ma

9 months ago
Pharma
FDA+

FDA OKs the first-ever self-ad­min­is­tered vac­cine, for flu

9 months ago
Pharma
FDA+

Eu­ro­pean reg­u­la­tors reaf­firm Apel­lis’ re­jec­tion, add eight pos­i­tive rec­om­men­da­tions

9 months ago
FDA+

Ali­gos’ tri­al for oral MASH treat­ment suc­ceeds, but place­bo group shows odd trend

9 months ago
R&D

4DMT's gene ther­a­py re­duced need for stan­dard-of-care in­jec­tions to treat age-as­so­ci­at­ed vi­sion loss

9 months ago
R&D
Cell/Gene Tx

FDA re­jects Van­da’s treat­ment for di­ges­tion con­di­tion, com­pa­ny re­bukes agen­cy's ac­tions

9 months ago
Pharma
FDA+

FDA ap­proves As­traZeneca’s asth­ma med­ica­tion Fasen­ra to treat rare au­toim­mune con­di­tion

9 months ago
Pharma
FDA+

Keytru­da adds new FDA ap­proval for a rare form of mesothe­lioma

9 months ago
R&D
Pharma

Roivant makes an­oth­er deal, sell­ing Der­ma­vant to Organon for up to $1.2B

9 months ago
Deals

No­vo Nordisk signs ge­net­ic med­i­cine pact, ink­ing deal with NanoVa­tion

9 months ago
Deals
First page Previous page 78910111213 Next page Last page
A service from the Financial Times